Reply to ‘Comment on ‘Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy’’ Letter uri icon

authors

  • Bowyer, Samantha
  • Prithviraj, Prashanth
  • Lorigan, Paul
  • Larkin, James
  • McArthur, Grant
  • Atkinson, Victoria
  • Millward, Michael
  • Khou, Muoi
  • Diem, Stefan
  • Ramanujam, Sangeetha
  • Kong, Ben
  • Liniker, Elizabeth
  • Guminski, Alexander
  • Parente, Phillip
  • Andrews, Miles C
  • Parakh, Sagun
  • Cebon, Jonathan
  • Long, Georgina V
  • Carlino, Matteo S
  • Klein, Oliver

publication date

  • April 2017